EMEA-001371-PIP01-12 - paediatric investigation plan
Clazakizumab
PIPHuman
CSL Behring GmbH
Tel. +49 151 44162443
E-mail: PIP.CSLBehring@cslbehring.com
P/0029/2014: European Medicines Agency decision of 13 February 2014 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for clazakizumab (EMEA-001371-PIP0...